Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 128

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 8
Chunk 128
---
2025Prepaid expenses and other current assets$3,434 $— $3,434 Total assets$3,434 $— $3,434 Accrued liabilities$2,971 $— $2,971 Other long-term liabilities— 2,084 2,084 Total liabilities$2,971 $2,084 $5,055 As of December 31, 2024Prepaid expenses and other current assets$6,716 $11,038 $17,754 Other assets— 5,724 5,724 Total assets$6,716 $16,762 $23,478 Accrued liabilities$7,391 $— $7,391 Total liabilities$7,391 $— $7,391 We recognized the following (losses) gains on our derivative instruments designated as cash flow hedges in other comprehensive income before reclassifications to net income (loss) (in thousands):(Losses) Gains Recognized in Other Comprehensive Income (Loss)Three months ended June 30,Six months ended June 30,2025202420252024Derivatives designated as cash flow hedging instruments:Foreign exchange forward contracts$1,830 $(3,965)$1,656 $975 Interest rate swaps(7,974)4,512 (12,065)17,905 Total derivatives designated as cash flow hedging instruments$(6,144)$547 $(10,409)$18,880 

21

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):Gains (Losses) Reclassified From Accumulated Other Comprehensive Income (Loss) into IncomeThree months ended June 30,Six months ended June 30,Location of Gains (Losses)  Recognized in Net Loss2025202420252024Derivatives designated as cash flow hedging instruments:Foreign exchange forward contractsTotal revenues$164 $633 $874 $1,333 Foreign exchange forward contractsCost of goods sold(393)1,059 (1,407)2,339 Interest rate swapsInterest expense3,316 7,291